Initial studies documented that RBP4 levels were elevated in patients with obesity, impaired glucose tolerance and T2DM, and were correlated with HbA1c, fasting glucose and insulin [5]. Here, RBP4 is linked to obesity due to melanocortin 4 receptor deficiency.